A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD).
Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...
Prevent Blindness, the nation's leading nonprofit eye health organization, is announcing Dec. 2-8, 2024, as its fourth annual Geographic Atrophy (GA) Awareness Week. GA is an advanced form of dry ...
Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...
HAYWARD, CA, USA I1, 2024 I Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first ...
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ...
The US FDA has issued a CRL for sNDA of Astellas Pharma’s IZERVAY, a treatment for geographic atrophy (GA) secondary to AMD.
Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...
The U.S. FDA issued a complete response letter Nov. 15 for Izervay’s (avacincaptad pegol intravitreal solution, ACP) supplemental NDA, which sought to include positive two-year data for the Astellas ...
What is laser photocoagulation for AMD? Laser photocoagulation is a type of laser surgery for the eyes. It's done to treat age-related macular degeneration (AMD). AMD can lead to vision loss. The ...